Novel BET Inhibitor PLX51107 for Steroid-Refractory Acute GVHD

NCT04910152 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Sponsor decision

Conditions

Acute Graft Versus Host Disease
Steroid Refractory Graft Versus Host Disease

Interventions

DRUG: BRD4 Inhibitor PLX51107

Sponsor

Hannah Choe, MD

Collaborators

[object Object]
[object Object]